Business Context and Reporting Period
Company: Altisource Portfolio Solutions S.A.
Filing Type: Form 8-K (Current Report)
Date of Report: March 31, 2025
Reporting Period: Event-based report regarding the entry into a Material Definitive Agreement and the execution of a Warrant Distribution.
Key Financial Metrics
This filing is a current report regarding a corporate action and does not contain audited financial statements, revenue, profit, cash flow, or debt metrics for the period. The filing text does not provide a clear value for these financial indicators.
Material Changes and Corporate Actions
The Company has satisfied the conditions required to proceed with a previously proposed Warrant Distribution to holders of Common Stock, Restricted Share Units (RSUs), and Penny Warrants as of the Distribution Record Date (February 14, 2025). The Company entered into a Warrant Agent Agreement with Equiniti Trust Company, LLC, dated March 31, 2025.
- Warrant Structure: Stakeholders receive two types of warrants for each eligible security held:
- Cash Exercise Stakeholder Warrants: Entitle the holder to purchase 1.625 shares of Common Stock per eligible unit.
- Net Settle Stakeholder Warrants: Entitle the holder to purchase 1.625 shares of Common Stock per eligible unit on a cashless basis.
- Exercise Price: $1.95 per Warrant (initially equivalent to $1.20 per share of Common Stock).
- Exercise Commencement: The later of July 2, 2025, or the first date the VWAP of Common Stock equals or exceeds $1.20 for 15 consecutive trading days.
- Expiration Dates:
- Cash Exercise Warrants: April 2, 2029.
- Net Settle Warrants: April 30, 2032.
- Listing: Applications have been filed to list the warrants on the Nasdaq Global Select Market under symbols ASPSZ (Cash Exercise) and ASPSW (Net Settle), subject to approval.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the issuance of warrants, the distribution date, and the listing of warrants. Management cautions that actual results may differ materially due to various risks, including:
- Customer concentration and the timing of default-related referrals following the expiration of moratoriums.
- Macroeconomic conditions and regulatory changes.
- The adequacy of financial resources and liquidity to repay borrowings.
- Technology disruptions and data compliance requirements.
- Retention of key executives and employees.
No specific financial guidance or revenue outlook was provided in this document.
Investor Verification Checklist
- Verify the approval status of the Nasdaq listing applications for symbols ASPSZ and ASPSW.
- Confirm the exact number of eligible securities held as of the February 14, 2025 Distribution Record Date to calculate warrant entitlements.
- Monitor the Common Stock VWAP to determine the actual commencement date for warrant exercise (must exceed $1.20 for 15 consecutive days).
- Review the full Warrant Agent Agreement (Exhibit 4.1) for specific anti-dilution adjustment formulas and termination rights.
- Assess the potential dilution impact on existing shareholders upon the exercise of the new warrants.